BioXcel Therapeutics (BTAI) Asset Utilization Ratio (2022 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Asset Utilization Ratio of 0.02 for Q1 2026, down 64.23% year-over-year from 0.05 in Q1 2025, and up 20.37% quarter-over-quarter from 0.01 in Q4 2025.
BioXcel Therapeutics (BTAI) Asset Utilization Ratio (2022 - 2026) Analysis & Trends
BioXcel Therapeutics' Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 0.02 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 64.23% year-over-year to 0.02; the TTM figure through Mar 2026 stood at 0.02 (down 64.23% YoY), while the FY2025 annual figure was 0.02, down 61.87% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.02, up from 0.01 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.05 in Q4 2024, with the low at 0.0 in Q3 2022.
- The 5-year median for Asset Utilization Ratio is 0.02 (2026), against an average of 0.02.
- The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio soared 1758.22% in 2023, then tumbled 72.45% in 2025.
- BioXcel Therapeutics' Asset Utilization Ratio stood at 0.0 in 2022, then jumped by 852.32% to 0.02 in 2023, then soared by 227.82% to 0.05 in 2024, then sank by 72.45% to 0.01 in 2025, then advanced by 20.37% to 0.02 in 2026.
- Business Quant data shows BTAI's Asset Utilization Ratio at 0.02 in Q1 2026, 0.01 in Q4 2025, and 0.02 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.25 Mn | 24.25 Mn | 160,000.00 | 0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.02 |
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.02 |
| Jun 30, 2025 | 0.03 |
| Mar 31, 2025 | 0.05 |
| Dec 31, 2024 | 0.05 |
| Sep 30, 2024 | 0.04 |
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | 0.02 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |